How to Get Testosterone Enanthate in Louisiana

Who Can Prescribe Testosterone Enanthate in Louisiana

Any Louisiana-licensed physician (MD or DO) with an active DEA registration can prescribe testosterone enanthate. That is the simplest pathway. Nurse practitioners in Louisiana hold full practice authority after completing a 4,600-hour collaborative practice period under a physician, per the Louisiana State Board of Nursing guidelines and state scope-of-practice statutes. Physician assistants may also prescribe Schedule III substances under a supervising physician's delegation.

Endocrinologists and urologists see the highest volume of testosterone replacement therapy (TRT) patients, but primary care physicians write the majority of testosterone prescriptions nationally. A 2017 cross-sectional analysis found that primary care providers accounted for roughly 50% of all testosterone prescriptions in the U.S. [1]. In Louisiana, the same pattern holds. Baton Rouge, New Orleans, Shreveport, and Lafayette all have multiple primary care and men's health clinics offering TRT evaluations.

Telehealth has expanded access in rural parishes where endocrinology and urology offices may be hours away. Louisiana's telemedicine statute (La. R.S. 37:1271.1) permits prescribing controlled substances after an initial audio-video evaluation, provided the prescriber holds a Louisiana license. This means a patient in Calcasieu Parish or Ouachita Parish can complete an evaluation from home without driving to a metro-area clinic.

Telehealth Pathways for Testosterone Enanthate in Louisiana

Telehealth is the fastest route for most Louisiana residents. Several national platforms and Louisiana-based clinics offer virtual TRT consultations. A typical telehealth workflow takes three steps: order labs, complete a video visit, and receive your prescription at a pharmacy or by mail.

The labs usually arrive as a requisition sent to a Quest Diagnostics or Labcorp draw site. Louisiana has Quest locations in New Orleans, Baton Rouge, Metairie, Shreveport, Lafayette, Lake Charles, and Monroe. Labcorp operates additional draw sites across the state. Results return in 2 to 5 business days. Once a provider reviews labs and confirms a diagnosis of hypogonadism (typically defined as total testosterone below 300 ng/dL per the American Urological Association guidelines), the prescription is sent electronically [2].

The Endocrine Society's 2018 clinical practice guideline recommends against testosterone therapy in men with total testosterone above 300 ng/dL unless symptoms are clearly present and repeat testing confirms borderline levels [3]. Telehealth providers adhering to this guideline will require at least two morning blood draws showing low testosterone before initiating treatment, because testosterone levels fluctuate throughout the day and peak in early morning hours.

Most telehealth platforms ship testosterone enanthate from partnered 503A compounding pharmacies, with delivery arriving 5 to 10 business days after the prescription is finalized. Some platforms offer expedited shipping within Louisiana for an additional fee.

What Labs Are Required Before Starting

Louisiana prescribers follow national guidelines for pre-TRT bloodwork. The minimum panel includes total testosterone drawn between 7:00 and 10:00 AM (fasting), free testosterone (calculated or by equilibrium dialysis), complete blood count (CBC), comprehensive metabolic panel (CMP), and a lipid panel [3].

The CBC matters because testosterone stimulates erythropoiesis. The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (N=790 men aged 65 and older), demonstrated that testosterone gel increased hemoglobin by a mean of 1.0 g/dL in men with unexplained anemia [4]. While that effect is clinically desirable in anemic patients, it poses a polycythemia risk in men with already-normal hematocrit. A hematocrit above 54% is a contraindication to initiating testosterone and a trigger for dose reduction or therapeutic phlebotomy in men already on therapy, per Endocrine Society recommendations [3].

Additional labs that many Louisiana providers order include prostate-specific antigen (PSA) for men over 40, estradiol, sex hormone-binding globulin (SHBG), prolactin (to rule out pituitary pathology), and thyroid-stimulating hormone (TSH). PSA screening before TRT is endorsed by the American Urological Association. A baseline PSA above 4.0 ng/mL (or above 3.0 ng/mL in high-risk populations) warrants urology referral before starting testosterone [2].

Monitoring labs are repeated at 3 months, 6 months, and then every 6 to 12 months. The 3-month check is the most important. It confirms that trough testosterone sits within the target range (400 to 700 ng/dL for most patients) and that hematocrit has not crossed the safety threshold.

Louisiana 503A Compounding Pharmacies and Testosterone Enanthate

Louisiana licenses 503A compounding pharmacies through the Louisiana Board of Pharmacy. These pharmacies may compound testosterone enanthate in various concentrations (commonly 200 mg/mL or 250 mg/mL) when a patient-specific prescription is on file. They can ship directly to patients within the state.

A 503A pharmacy differs from a 503B outsourcing facility. Under the Drug Quality and Security Act of 2013, 503A pharmacies compound individual prescriptions, while 503B facilities produce larger batches under FDA oversight and current good manufacturing practice (cGMP) requirements [5]. Both operate legally in Louisiana. Several national 503B outsourcing facilities also ship testosterone enanthate to Louisiana addresses.

Cost through a 503A compounder typically ranges from $50 to $120 for a 10 mL vial (200 mg/mL), depending on the pharmacy and whether the patient uses insurance or pays cash. Brand-name testosterone enanthate (Delatestryl) and generics from manufacturers like Perrigo or Hikma are available at retail pharmacies (CVS, Walgreens, Walmart) for $30 to $90 per 5 mL vial with a GoodRx-type discount coupon. Insurance copays vary widely.

Patients should verify that any compounding pharmacy they use holds an active Louisiana Board of Pharmacy license and, if shipping from out of state, a valid non-resident pharmacy license. The Louisiana Board of Pharmacy maintains a searchable license verification tool on its website.

Insurance Coverage and Prior Authorization in Louisiana

Louisiana Medicaid does not cover testosterone enanthate for male hypogonadism. This exclusion applies to both fee-for-service Medicaid and managed care organizations (MCOs) operating under Medicaid contracts in the state. Patients enrolled in Louisiana Medicaid who need testosterone therapy will generally pay out of pocket.

Commercial insurance plans in Louisiana (Blue Cross Blue Shield of Louisiana, Aetna, Cigna, UnitedHealthcare, and Humana, among others) do cover testosterone enanthate in many cases, but most require prior authorization. The prior authorization process typically requires the following documentation:

Two separate morning serum total testosterone levels below 300 ng/dL (or the plan's stated threshold), a documented clinical diagnosis of hypogonadism with ICD-10 code E29.1, evidence that symptoms are present (fatigue, decreased libido, erectile dysfunction, mood disturbance, or loss of lean mass), and lab confirmation that secondary causes have been evaluated (prolactin, TSH, iron studies if indicated) [2].

Some plans also require documentation that the prescriber has discussed fertility implications with the patient. Exogenous testosterone suppresses spermatogenesis through negative feedback on the hypothalamic-pituitary-gonadal axis. The FDA label for testosterone enanthate carries a warning about this effect [5]. For men who wish to preserve fertility, prescribers may consider alternatives like clomiphene citrate (off-label) or human chorionic gonadotropin (hCG) before initiating testosterone.

Prior authorization turnaround in Louisiana averages 3 to 7 business days. If denied, patients have the right to an expedited appeal, which Louisiana insurance regulations require to be resolved within 72 hours for urgent cases.

Dosing, Administration, and Follow-Up in Louisiana

The standard testosterone enanthate protocol is 100 to 200 mg intramuscularly once weekly or 200 mg every two weeks, per the FDA-approved prescribing information [5]. Many TRT clinicians in Louisiana prefer weekly injections to reduce the peak-trough fluctuations that occur with biweekly dosing.

Dr. Shalender Bhasin, principal investigator of several landmark testosterone trials, has stated: "Physiologic testosterone replacement improves sexual function, mood, and body composition in men with unequivocally low testosterone, but the benefits must be weighed against potential cardiovascular and erythrocytosis risks on an individual basis" [4]. This framing guides Louisiana prescribers who follow evidence-based practice.

Self-injection is standard for most patients. Clinics teach intramuscular injection technique (vastus lateralis or ventrogluteal site) during the initial visit or via instructional video for telehealth patients. Some patients prefer subcutaneous injection with a 27-gauge needle, a method supported by pharmacokinetic data showing comparable testosterone levels with lower injection-site pain [6].

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, provided the first large-scale randomized data on cardiovascular safety of testosterone replacement. The trial found no increased incidence of major adverse cardiovascular events (MACE) in men aged 45 to 80 with hypogonadism and pre-existing or high risk for cardiovascular disease, with a hazard ratio of 0.96 (95% CI, 0.78 to 1.17) [7]. This result led to updated clinical guidance from the AUA and Endocrine Society, easing some prior concerns about cardiovascular risk.

Louisiana law requires that Schedule III prescriptions be filled within 6 months of the date written. Testosterone enanthate prescriptions can include up to five refills within that 6-month window. After 6 months, a new prescription is required, which typically coincides with follow-up labs and a clinical reassessment.

Transferring a Prescription to Louisiana

Patients moving to Louisiana or traveling for extended periods can transfer an existing testosterone enanthate prescription from another state. Louisiana Board of Pharmacy regulations permit controlled substance prescription transfers between pharmacies, though each transfer counts as one of the authorized refills.

The receiving Louisiana pharmacy contacts the originating pharmacy to verify the prescription, remaining refills, and prescriber information. This process usually takes 24 to 48 hours. Patients should bring their current vial, a copy of recent labs, and their prescriber's contact information to speed the transfer.

If the original prescription was written by a provider not licensed in Louisiana, the patient will need to establish care with a Louisiana-licensed prescriber for ongoing refills. Telehealth platforms simplify this transition. A new-patient telehealth visit with recent labs (within 3 to 6 months) can often result in a new Louisiana prescription within days.

What to Expect: Timeline from Start to First Injection

The complete timeline from initial inquiry to first injection typically spans 7 to 14 days through telehealth and 10 to 21 days through traditional in-person clinics. Here is the breakdown for a telehealth pathway:

Day 1 to 2: Sign up, complete intake questionnaire, receive lab order. Day 2 to 5: Visit a draw site, have blood drawn. Day 5 to 8: Lab results return, provider reviews them. Day 8 to 9: Video consultation, prescription sent. Day 9 to 14: Pharmacy fills and ships medication. Some Louisiana-based telehealth clinics with in-house dispensing can compress this timeline to 5 to 7 days total.

For in-person clinics, add 3 to 7 days for appointment availability. Endocrinology referrals in Baton Rouge and New Orleans may have wait times of 4 to 8 weeks, making primary care or telehealth the faster option for straightforward hypogonadism evaluations.